JP Morgan Healthcare Conference & Biotech Showcase 2023
We know that groundbreaking biotech innovators require experienced, agile partners who put an emphasis on the needs of today while preparing for the potential of tomorrow.
With over 30 years of experience working closely with biotech companies, including almost every new therapeutic category across all points along the asset development and commercialization continuum, Syenos Health promises transparency and agility with our unique position to address ever-evolving biotech dynamics with relevant, efficient custom solutions.
Be sure to find us in San Francisco at the J.P. Morgan Healthcare Conference and Biotech Showcase events.
Or, schedule a time to meet with our team to discuss your product development challenges.
Biotech Showcase Featured Panels
Headwinds or Not: Moving Forward Despite the Challenging Environment
Monday January 9 | 12-1:30pm PT
Lee Taurman, EVP and Global Head, Syneos One, Syneos Health
Investir pour la réussite commerciale en tant qu’entreprise émergente
Monday January 9 | 4-5pm PT
Sachin Purwar, Managing Director, Syneos Health Consulting
Dealmaker’s Intentions 2023—Annual Report
Tuesday January 10 | 4-5pm PT
Neel Patel, Executive Managing Director, Syneos Health Consulting
Additional Details
Vous voulez en savoir plus? Explore Insights Hub
or click on the resources below:
2023 Health Trends: Personally, Purposefully Building What’s Next
La solution gagnante de l’externalisation complète pour les sociétés biopharmaceutiques émergentes
Balado de Syneos Health : Solutions commerciales complètes
Fireside Chat: Product Commercialization in 2022
La nouvelle stratégie d’accès au marché pour les biotechnologies émergentes
Investing for Launch Success: Finding the Right Balance
